


ASPH R&D
297 posts

@ASPH_RD
Research & Development Department for Ashford & St Peter's Hospitals NHS Foundation Trust 🌈💙




Trish has given me permission to tweet this video, after a very tough month and an emotional tiring battle with Covid this lady was discharged from #ASPH Aspen ward on Thursday, every member of our team has helped her to overcome this dreadful virus. Well done to everyone 🙂🥳👏







"A game-changer" according to scientists involved. Trials are starting on a nasal spray which could be 99.9% effective at killing coronavirus. Virologists at @ASPHFT think it could potentially treat people up to 4 days after infection. Exclusive access for @itvlondon.

BREAKING: The RECOVERY trial finds no overall benefit for convalescent plasma in moderately ill patients taking part. It has now closed recruitment to this treatment arm for all hospitalised patients. A huge thanks to everyone who took part & donated blood recoverytrial.net/news/statement…







Welcome to the DEFEAT-COVID clinical trial. We are trying to establish if leflunomide, used for rheumatoid arthritis, is clinically effective against COVID infection. We are looking to open new sites; contact megan.mcgee@nhs.net or kieran.brack1@nhs.net for info.











